Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jul 2, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Revance Therapeutics, Inc.
1K
$2.18
$2,184.50
+0.52%
193.67K
Jun 30
Revance Therapeutics, Inc.
-13.18K
$5.12
-$67,479.49
-6.40%
192.67K
Mar 15 - Mar 18
Revance Therapeutics, Inc.
17.45K
—
—
+9.26%
205.85K
Feb 29
Revance Therapeutics, Inc.
96.67K
—
—
+105.38%
188.4K
Jan 31
Revance Therapeutics, Inc.
434
$7.47
$3,241.98
+0.48%
91.73K
Dec 31
Revance Therapeutics, Inc.
11.4K
$18.91
-$212,075.65
+14.27%
91.3K
Aug 11
Revance Therapeutics, Inc.
-932.00
$20.33
-$30,592.03
-1.15%
79.9K
Jun 30 - Jul 3
Revance Therapeutics, Inc.
-3.20K
$30.64
-$98,069.57
-3.81%
80.83K
Jun 1 - Jun 2
Revance Therapeutics, Inc.
20.95K
$34.55
-$739,338.21
+33.21%
84.03K
Feb 2 - May 15
Revance Therapeutics, Inc.
-3.20K
$31.70
-$101,471.70
-4.83%
63.08K
May 1
Revance Therapeutics, Inc.
-3.20K
$32.15
-$102,912.15
-4.61%
66.28K
Apr 3
Revance Therapeutics, Inc.
-3.74K
$30.65
-$114,600.35
-5.11%
69.48K
Mar 15
Revance Therapeutics, Inc.
23.83K
$31.59
-$584,883.52
+48.25%
73.22K
Sep 22 - Mar 9
Revance Therapeutics, Inc.
-3.20K
$33.50
-$107,233.50
-6.09%
49.39K
Mar 1
Scheduled
Revance Therapeutics, Inc.
-2.08K
$33.21
-$69,242.85
-3.81%
52.59K
Feb 15
Revance Therapeutics, Inc.
-3.20K
$34.60
-$110,754.60
-5.53%
54.68K
Jan 31 - Feb 1
Scheduled
Revance Therapeutics, Inc.
-1.00K
$31.00
-$31,000.00
-1.70%
57.88K
Jan 20
Scheduled
Revance Therapeutics, Inc.
-3.70K
$27.16
-$100,525.00
-5.91%
58.88K
Jan 9
Scheduled
Revance Therapeutics, Inc.
645
$12.18
$7,856.42
+1.04%
62.58K
Dec 31
Revance Therapeutics, Inc.
-1.56K
$21.50
-$33,475.50
-2.45%
61.93K
Dec 15
Revance Therapeutics, Inc.
965
$11.75
$11,335.86
+1.54%
63.49K
Jun 30
Revance Therapeutics, Inc.
-2.61K
$15.79
-$41,164.53
-4.00%
62.52K
Mar 15
Revance Therapeutics, Inc.
-2.92K
$13.35
-$39,035.40
-4.30%
65.13K
Feb 15
Revance Therapeutics, Inc.
0
—
—
—
0
Feb 2
Revance Therapeutics, Inc.
404
$13.87
$5,604.29
+0.60%
68.06K
Dec 31
Revance Therapeutics, Inc.
-1.56K
$15.92
-$24,771.52
-2.25%
67.65K
Dec 15
Revance Therapeutics, Inc.
446
$24.09
$10,743.69
+0.65%
69.21K
Jun 30
Revance Therapeutics, Inc.
-2.66K
$28.97
-$76,973.29
-3.72%
68.76K
Feb 15
Revance Therapeutics, Inc.
22.62K
—
—
+46.35%
71.42K
Feb 2
Revance Therapeutics, Inc.
493
$21.36
$10,530.73
+1.02%
48.8K
Dec 31
Revance Therapeutics, Inc.
-1.56K
$26.75
-$41,623.00
-3.12%
48.31K
Dec 15
Revance Therapeutics, Inc.
10.3K
$25.14
-$136,912.44
+26.05%
49.86K
Sep 30
Revance Therapeutics, Inc.
763
$13.80
$10,525.97
+1.97%
39.56K
Jun 30
Revance Therapeutics, Inc.
-576.00
$25.33
-$14,590.08
-1.46%
38.8K
Feb 15
Revance Therapeutics, Inc.
16.5K
—
—
+72.14%
39.37K
Jan 23
Revance Therapeutics, Inc.
504
$10.82
$5,453.28
+2.25%
22.87K
Dec 31
Revance Therapeutics, Inc.
-1.56K
$15.99
-$24,880.44
-6.50%
22.37K
Dec 15
Revance Therapeutics, Inc.
923
$11.02
$10,175.61
+4.01%
23.92K
Jun 28
Revance Therapeutics, Inc.
5K
—
—
+27.78%
23K
Jan 24
Revance Therapeutics, Inc.
18K
—
—
∞
18K
Nov 5

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.